RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析

◆英語タイトル:RegeneRx Biopharmaceuticals Inc (RGRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81612FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its business development services include clinical development and commercialization interests in desired pharmaceutical therapeutic fields for suitable infrastructure, expertise and a long-term initiative in disease areas. RegeneRx’s research areas include neurologic and stroke; cytoskeletal research; renal disease, renal organogenesis and fibrosis; dermal scarring, stem cell, cardiovascular reperfusion injury, ophthalmic mechanisms of repair, cosmeceuticals, burns and pulmonary arterial hypertension. The company conducts research and development on novel pharmaceuticals, which protect and repair tissue and organ damage. It collaborates with universities, hospitals, and medical research institutions worldwide. RegeneRx is headquartered in Rockville, Maryland, the US.

RegeneRx Biopharmaceuticals Inc Key Recent Developments

Mar 18,2021: RegeneRx Reports Topline Results of ARISE-3 Dry Eye Trial
Feb 24,2021: RegeneRx JV Locks Clinical Trial Database for Phase 3 Dry Eye Trial
Sep 08,2020: New research paper suggests RegeneRx’s thymosin beta 4 may be useful in treating COVID-19

This comprehensive SWOT profile of RegeneRx Biopharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of RegeneRx Biopharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

RegeneRx Biopharmaceuticals Inc – Key Information
RegeneRx Biopharmaceuticals Inc – Overview
RegeneRx Biopharmaceuticals Inc – Key Employees
RegeneRx Biopharmaceuticals Inc – Key Employee Biographies
RegeneRx Biopharmaceuticals Inc – Key Operational Heads
RegeneRx Biopharmaceuticals Inc – Major Products and Services
RegeneRx Biopharmaceuticals Inc – History
RegeneRx Biopharmaceuticals Inc – Company Statement
RegeneRx Biopharmaceuticals Inc – Locations And Subsidiaries
RegeneRx Biopharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

RegeneRx Biopharmaceuticals Inc – Business Description
RegeneRx Biopharmaceuticals Inc – Corporate Strategy
RegeneRx Biopharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
RegeneRx Biopharmaceuticals Inc – Strengths
RegeneRx Biopharmaceuticals Inc – Weaknesses
RegeneRx Biopharmaceuticals Inc – Opportunities
RegeneRx Biopharmaceuticals Inc – Threats
RegeneRx Biopharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

RegeneRx Biopharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

RegeneRx Biopharmaceuticals Inc, Key Information
RegeneRx Biopharmaceuticals Inc, Key Ratios
RegeneRx Biopharmaceuticals Inc, Share Data
RegeneRx Biopharmaceuticals Inc, Major Products and Services
RegeneRx Biopharmaceuticals Inc, History
RegeneRx Biopharmaceuticals Inc, Key Employees
RegeneRx Biopharmaceuticals Inc, Key Employee Biographies
RegeneRx Biopharmaceuticals Inc, Key Operational Heads
RegeneRx Biopharmaceuticals Inc, Other Locations
RegeneRx Biopharmaceuticals Inc, Subsidiaries
RegeneRx Biopharmaceuticals Inc, Key Competitors
RegeneRx Biopharmaceuticals Inc, SWOT Analysis
RegeneRx Biopharmaceuticals Inc, Ratios based on current share price
RegeneRx Biopharmaceuticals Inc, Annual Ratios
RegeneRx Biopharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intersil Corporation (ISIL):企業の財務・戦略的SWOT分析
    Intersil Corporation (ISIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Nyrstar NV:企業の戦略・SWOT・財務情報
    Nyrstar NV - Strategy, SWOT and Corporate Finance Report Summary Nyrstar NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Carlisle Coatings & Waterproofing Inc:企業の戦略的SWOT分析
    Carlisle Coatings & Waterproofing Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • ARM Ltd.:企業の戦略・SWOT・財務分析
    ARM Ltd. - Strategy, SWOT and Corporate Finance Report Summary ARM Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Precision System Science Co Ltd (7707):企業の財務・戦略的SWOT分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company provide products such as automated nucleic acid isolation system, large sample volume nucleic acid extract …
  • Burnet Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Burnet Institute is a non-profit and independent organization that improves health of poor and vulnerable communities through research, education and public health. The institute offers solutions to major health issues through development and discovery of novel vaccines, diagnostic tests and …
  • F1 Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary F1 Oncology Inc (F1 Oncology) is a developer of adoptive cellular therapy candidates. The company develops CAB technology to mitigate the on-target, off-tumor toxicity of Chimeric Antigen Receptor (CAR) T cell therapy. It is developing CAB technology. The company’s drugs are used in rewiring …
  • LyondellBasell Industries NV (LYB):企業の財務・戦略的SWOT分析
    LyondellBasell Industries NV (LYB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Lantheus Medical Imaging Inc-医療機器分野:企業M&A・提携分析
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • Advaxis Inc (ADXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Advaxis Inc (Advaxis) is a biotechnology company that focuses on the discovery, development and commercialization of multiple cancer immunotherapies. The company develops immunotherapies based on its proprietary Lm Technology that uses bioengineered live attenuated Listeria monocytogenes (Lm …
  • Southwest Airlines Co:戦略・SWOT・企業財務分析
    Southwest Airlines Co - Strategy, SWOT and Corporate Finance Report Summary Southwest Airlines Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Power Assets Holdings Limited (6):電力:M&Aディール及び事業提携情報
    Summary Power Assets Holdings Limited (Power Assets) a subsidiary of CK Infrastructure Holdings Limited, is an investment holding company. The company through its subsidiaries, joint ventures, and affiliates, invests in power and utility-related businesses. The company has interests in electricity g …
  • Kraftwerke Oberhasli AG:企業の戦略的SWOT分析
    Kraftwerke Oberhasli AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Engie Brasil Energia SA (EGIE3):電力:M&Aディール及び事業提携情報
    Summary Engie Brasil Energia SA (Engie Brasil), formerly Tractebel Energia SA, a subsidiary of Engie SA, undertakes the generation and commercialization of electricity. It generates energy through various source of energy such as hydro; thermal; and complementary energy sources including wind, solar …
  • Parexel International Corp:医療機器:M&Aディール及び事業提携情報
    Summary Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of …
  • J. Knipper and Company Inc:企業の戦略的SWOT分析
    J. Knipper and Company Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Software AG:企業の戦略・SWOT・財務情報
    Software AG - Strategy, SWOT and Corporate Finance Report Summary Software AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Banco de Sabadell, S.A.:戦略・SWOT・企業財務分析
    Banco de Sabadell, S.A. - Strategy, SWOT and Corporate Finance Report Summary Banco de Sabadell, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • High Plains Power Inc:企業の戦略的SWOT分析
    High Plains Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Krung Thai Bank PCL:企業の戦略・SWOT・財務分析
    Krung Thai Bank PCL - Strategy, SWOT and Corporate Finance Report Summary Krung Thai Bank PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆